OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Purchased by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. raised its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 1.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 251,588 shares of the company’s stock after acquiring an additional 4,728 shares during the period. Harbor Capital Advisors Inc. owned approximately 1.04% of OrthoPediatrics worth $5,832,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Quarry LP purchased a new position in OrthoPediatrics during the third quarter worth about $25,000. International Assets Investment Management LLC increased its position in OrthoPediatrics by 2,610.8% during the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after purchasing an additional 966 shares during the period. Quest Partners LLC purchased a new position in shares of OrthoPediatrics during the 2nd quarter worth approximately $34,000. BNP Paribas Financial Markets lifted its holdings in shares of OrthoPediatrics by 125.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after buying an additional 1,929 shares during the period. Finally, Quantbot Technologies LP boosted its stake in shares of OrthoPediatrics by 42.2% in the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock valued at $157,000 after buying an additional 1,712 shares in the last quarter. 69.05% of the stock is owned by institutional investors and hedge funds.

OrthoPediatrics Trading Up 1.1 %

Shares of KIDS stock opened at $24.44 on Friday. The stock has a market cap of $591.84 million, a P/E ratio of -19.87 and a beta of 1.14. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. OrthoPediatrics Corp. has a fifty-two week low of $21.02 and a fifty-two week high of $35.99. The business has a fifty day simple moving average of $24.33 and a 200-day simple moving average of $27.47.

Analyst Upgrades and Downgrades

KIDS has been the topic of several research analyst reports. Needham & Company LLC restated a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Friday, November 8th. JMP Securities reissued a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Truist Financial dropped their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.